Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Algernon’s business model is based on drug re-purposing, finding new uses for know drugs





 

Bullboard - Investor Discussion Forum Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Bullboard (CSE:AGN)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by nodaytraderon May 03, 2024 11:22am

Yesterday’s Trading

Great was the joy in the sandbox yesterday at the return of Integral after a lengthy absence. Its single trade was an eye-watering $55 from Desjardins, that knocked $200,000 off the value of Algernon ...more  
53
Comment by nodaytraderon May 01, 2024 5:09pm

RE:Webinar Recap: $AGN CEO Chris Moreau and Radius Research

We learn in the video of Algernon's potential bring relief from suffering to millions of people around the world. we also learned of the company's great difficulty in raising research capital ...more  
35
Discussion
Post by bmreedon Apr 10, 2024 2:07pm

Webinar $AGN CEO Chris Moreau Tue Apr 16 @ 4PM ET / 1PM PT

RESCHEDULED: Live Webinar - Algernon Pharmaceuticals $AGN w/ CEO Christopher Moreau Tuesday, April 16th at 4PM ET / 1PM PT Q&A with Radius Research  Register Here - https://us02web ...more  
73
Post by nodaytraderon Mar 21, 2024 10:09am

Tuesday’s Trading

Out of the country so catching up . Tursday's trading brought the price by one cent and the usual kids in the sandbox were involved. Howevee, there was one interesting new player- Credential ...more  
92
Post by nodaytraderon Mar 07, 2024 5:02pm

Today’s Trading

Same old same old. Desjardins and National flinging nickels around like manhole covers.
66
Post by nodaytraderon Feb 23, 2024 7:24pm

Today’s Trading

No Trading  in the sandbox today -unless you count the Quebec kids, Laurentian  and Desjardiin the 
79
Post by nodaytraderon Feb 06, 2024 5:01pm

Today’s Trading

A busy day in the sandbox with over 100,000 shares traded. The Quebec kids were very active and the price dropped one cent today, like yesterday, to finish at 7 cents. Meanwhile at OTC, with no ...more  
110
Post by nodaytraderon Feb 05, 2024 5:07pm

Today’s Trading

Relatively big spread  bid and ask 08/095 for about four hours then three trades at $0.08 all from TDSecurities and all to the Quebec kids I wonder who owned the TD account.
85
Post by nodaytraderon Feb 01, 2024 4:29pm

Today’s Trading

Moderate trading, sans Quebec, and price rises to 9 cents. late in the day we had two mini trades - totalling $240, and involving the Quebec kids exclusively, brought the price down to 8 cents, for ...more  
73
Post by nodaytraderon Jan 29, 2024 2:40pm

Today’s Trading

BC based AGN is down today. All trades so far have been between the Quebec kids, Desjardins and National Bank, exclusively.
56
Post by nodaytraderon Jan 18, 2024 4:37pm

Today’s Trading

Only three trades today -all involving, exclusively, Desjardins and National Bank. The Quebec kids are now in charge of the sandbox.
61
Post by nodaytraderon Jan 09, 2024 6:41pm

Today’s Trading

Interesting! Seven (7) trades today. After closing at 0.095 yesterday and hours of inactivity today, Desjardins makes an $85 trade so the market price is 0.085. Next we have TD Securities buying 2000 ...more  
116
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Connect with C.AGN


PIPELINE TARGETED DISEASES MEDIA MANAGEMENT

CEO Clips: DMT Clinical Trial

CEO Q&A Interview with Chris Moreau

Investor Presentation

Download the latest Investor Presentaion

Algernon Highlights: The Watchlist

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Investment Opportunity

The Algernon Value Proposition



  • Advancing new drug treatments for billion dollar global disease markets.
  • Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.
  • Conducting multiple phase II clinical trials.
  • Highly capital efficient business model.
  • Experienced management team & globally recognized medical advisory board.

Facebook

Contact Us